Product Images Sodium Phenylacetate And Sodium Benzoate

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 4 images provide visual information about the product associated with Sodium Phenylacetate And Sodium Benzoate NDC 68382-396 by Zydus Pharmaceuticals Usa Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

figure-1 - e99193a4 96eb 4950 af3c b3acc42dae59 01

figure-1 - e99193a4 96eb 4950 af3c b3acc42dae59 01

figure-2 - e99193a4 96eb 4950 af3c b3acc42dae59 02

figure-2 - e99193a4 96eb 4950 af3c b3acc42dae59 02

vial-label - e99193a4 96eb 4950 af3c b3acc42dae59 03

vial-label - e99193a4 96eb 4950 af3c b3acc42dae59 03

Sodium Phenylacetate and Sodium Benzoate Injection is a sterile, concentrated solution that must be diluted with sterile, dextrose injection before intravenous administration for intravenous use only. The lot number and expiration date are provided on the packaging, and the single-dose vial contains 100 mg of sodium phenylacetate and 100 g of Sodium benzoate, along with water for injection. It is important to administer the injection through a central line to avoid causing burns. This product is distributed by Zydus Pharmaceuticals USA Inc. and must be stored at 25°C (77°F) with excursions permitted to 15°-30°C (59°-86°F). The dosage information is provided in the accompanying insert.*

carton-label - e99193a4 96eb 4950 af3c b3acc42dae59 04

carton-label - e99193a4 96eb 4950 af3c b3acc42dae59 04

This is a description of a medication with the NDC code 68382-396-01, which is for Rx Only use. The medication is called Sodium Phenylacetate and Sodium Benzoate Injection and comes in a 50mL container. The medication is for intravenous use only and must be diluted before administration with sterile, dextrose injection, 10% (D10W). Each mL of the medication contains 100 mg of sodium phenylacetate and 100 mg of sodium benzoate along with water for injection. The medication's pH may have been adjusted with sodium hydroxide or hydrochloric acid. The dosage information can be found in the accompanying package insert. The medication should be stored at 25°C (77°F), with permitted excursions to 15°-30°C (59°-86°F), and should be kept out of reach of children. Zydus Pharmaceuticals USA Inc. distributes the medication.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.